WT1 and neoplasm: Additional experiments performed in Batf3−/− knockout mice deficient for both CD103+ and CD8α+ DCs29, 43 revealed an absence of the WT1 vaccine-mediated protective responses (Figure 6H), stressing the need for CD103+ DCs at the tumor site for induction of antitumor protective immune responses.